Bond Bristol Myers Squibb Inc. 4.55% ( US110122DL93 ) in USD
| Issuer | Bristol Myers Squibb Inc. |
| Market price | |
| Country | United States
|
| ISIN code |
US110122DL93 ( in USD )
|
| Interest rate | 4.55% per year ( payment 2 times a year) |
| Maturity | 19/02/2048 |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 2 000 USD |
| Total amount | 1 447 340 000 USD |
| Cusip | 110122DL9 |
| Standard & Poor's ( S&P ) rating | A ( Upper medium grade - Investment-grade ) |
| Moody's rating | A2 ( Upper medium grade - Investment-grade ) |
| Next Coupon | 20/02/2026 ( In 13 days ) |
| Detailed description |
Bristol Myers Squibb is a global biopharmaceutical company engaged in the research, development, and marketing of innovative medicines, primarily focused on oncology, cardiovascular disease, immunology, and fibrosis. The Bond issued by Bristol Myers Squibb Inc. ( United States ) , in USD, with the ISIN code US110122DL93, pays a coupon of 4.55% per year. The coupons are paid 2 times per year and the Bond maturity is 19/02/2048 The Bond issued by Bristol Myers Squibb Inc. ( United States ) , in USD, with the ISIN code US110122DL93, was rated A2 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Bristol Myers Squibb Inc. ( United States ) , in USD, with the ISIN code US110122DL93, was rated A ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
Français
Italiano
United States